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Abstract
Background: Prolonged mechanical ventilation is increasingly common. It is expensive and associated with significant morbidity and 
mortality. Our objective is to comprehensively characterize patients admitted to a Ventilator Rehabilitation Unit (VRU) for weaning and 
identify characteristics associated with survival.
Methods: 182 consecutive patients over 3.5 years admitted to Temple University Hospital (TUH) VRU were characterized. Data were 
derived from comprehensive chart review and a prospectively collected computerized database. Survival was determined by hospital 
records and social security death index and mailed questionnaires.
Results: Upon admission to the VRU, patients were hypoalbuminemic (albumin 2.3 ± 0.6 g/dL), anemic (hemoglobin 9.6 ± 1.4 g/dL), 
with moderate severity of illness (APACHE II score 10.7 + 4.1), and multiple comorbidities (Charlson index 4.3 + 2.3). In-hospital 
mortality (19%) was related to a higher Charlson Index score (P = 0.006; OR 1.08–1.6), and APACHE II score (P = 0.016; OR 1.03–1.29). 
In-hospital mortality was inversely related to admission albumin levels (P = 0.023; OR 0.17–0.9). The presence of COPD as a comorbid 
illness or primary determinant of respiratory failure and higher VRU admission APACHE II score predicted higher long-term mortality. 
Conversely, higher VRU admission hemoglobin was associated with better long term survival (OR 0.57–0.90; P = 0.0006).
Conclusion: Patients receiving prolonged ventilation are hypoalbuminemic, anemic, have moderate severity of illness, and multiple 
comorbidities. Survival relates to these factors and the underlying illness precipitating respiratory failure, especially COPD.
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Introduction
Prolonged mechanical ventilation (PMV), generally 
defined as .14–21 days of continuous ventilation, is 
provided to an increasing number of patients leading 
to  greater  intensive  care  unit  (ICU)  patient-days, 
resource consumption and costs. About 2%–5% of 
the ICU population fit into this category which now 
accounts for 37% of all ICU costs.12 The financial 
burden of caring for an increased numbers of patients 
receiving prolonged ventilation has prompted acute 
care hospitals to transfer patients from the ICU to 
alternative sites of care for further weaning attempts 
and  treatment.2  These  alternative  sites  of  care  are 
usually  geographically  separate  and  have  different 
medical, nursing, and ancillary staff patterns from the 
originating acute care hospital.3 Post-ICU ventilator 
facilities vary in purpose, organization and financial 
structure. A commercial model, called a long-term 
acute care facility (LTAC) contrasts to a not-for profit 
model such as a VRU or other dedicated weaning unit 
where the primary goal and direction of resources is 
toward progression of the patient toward ventilator 
independence and discharge toward home.
Survival  to  discharge  data  from  non-ICU,  non-
acute care hospital weaning centers are varied, and 
range between 50%–94%. One year post discharge 
survival is reported between 23% and 53% with 3 year 
reported data between 25% and 56%.4–8 Morbidity 
among survivors is high.9 The variability in survival 
data reflects differences in single center patient selec-
tion, patient care practice, patient characteristics and 
outcomes reporting. With these limitations in mind 
we describe 182 patients treated over 3.5 years.
Herein,  we  present  a  comprehensive  clinical  and 
demographic  characterization  of  patients  receiving 
  prolonged  ventilation  and  describe  their  short-term 
(eg,  at  hospital  discharge),  and  long-term  survival 
(eg, years after discharge). Additionally, we describe the 
factors that are associated with an improved survival.
Methods
Setting
The VRU is an 18 bed unit within TUH. The unit 
is  staffed  by  a  board-certified  pulmonary/critical 
care attending who leads the multidisciplinary team 
(Fig. 1). In addition to individualized and optimized 
medical  care,  all  patients  receive  daily  aggressive 
whole  body  rehabilitation  and  respiratory  muscle 
training and daily spontaneous breathing trials.
VRU admission and discharge criteria
Patients were referred from ICUs within the hospital 
(approximately  70%),  and  from  outside  ICUs, 
LTACs and nursing homes. Patients admitted to the 
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Figure 1. Outline of daily and long term planning in ventilator rehabilitation unit. 
Adapted from reference 28, with permission from the authors.
Abbreviation: DMe, durable medical equipment.Survival in prolonged ventilation
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VRU must breathe spontaneously $0.5 hours, have 
a tracheostomy, have hemodynamic stability and a 
willingness to participate in a physical rehabilitation 
program. Complete admission criteria are listed in 
Table 1. VRU discharge occurred upon resolution or 
control of medical illness, liberation from mechanical 
ventilation,  confirmed  need  for  home  mechanical 
ventilation,  or  ICU  transfer  for  new  or  worsening 
  medical condition. Timing of discharge was   influenced 
by patients’ level of social and psychological support, 
need for partial or total home mechanical ventilation 
or placement in skilled nursing facility for ongoing 
subacute care or nursing home placement.
Study patient selection
Data  were  collected  from  consecutive  patients 
  receiving prolonged mechanical ventilation   admitted 
to  the  VRU  from  1/2000  to  7/2004.  Clinical  and 
  demographic data were collected prospectively into an 
institutional review board (IRB) approved   database. 
The IRB approved all aspects of the study.
Classification of respiratory failure
Patients were classified by cause of respiratory failure. 
Seven diagnostic groups were acute respiratory distress 
syndrome  (ARDS)/Pneumonia,  chronic  obstructive 
pulmonary disease (COPD), congestive heart failure/
coronary  artery  disease  (CHF/CAD),  neurological 
(Neuro), obesity, trauma and post-thoracic transplanta-
tion (heart, lung or heart-lung). Prior studies grouped 
patients similarly 4–6,10 with the exception of the newly 
added, obesity and thoracic transplant groups.
Assessed variables
Primary outcomes were survival to hospital discharge 
and post-discharge survival to one and 3 years.   Survival 
was assessed for each of seven patient   categories of 
respiratory failure and according to the presence or 
absence of COPD as a primary or   comorbid diagnosis. 
Secondary outcomes were weaning from mechanical 
ventilatory  support,  and  post-VRU-discharge  dis-
position. Survival outcomes were determined from 
hospital and clinic records, the social security death 
index, and a questionnaire mailed to each patient’s 
last known address. Survival data collection termi-
nated 3 years after the last patient was discharged.
Clinical data included: facility of origin, total hos-
pital length of stay, length of ICU stay (defined as 
time spent in the ICU prior to VRU admission), length 
of VRU stay age, gender, co-morbidities using the 
Charlson index,11 APACHE II score, dialysis needs, 
body mass index (BMI), and presence or absence of 
the following CHF, COPD, diabetes mellitus (DM). 
Laboratory data included: serum albumin at hospital 
admission, at VRU admission and upon discharge, 
hemoglobin  at  VRU  admission  and    transfusion 
requirements pre and post-VRU admission. Ventilator 
data included: duration of mechanical ventilation, peak 
and plateau pressures at VRU admission and on the 
last day of mechanical ventilation, PaO2 and PaCO2 
arterial blood gas results and PaO2/FiO2 on ventilator 
support  at  VRU  admission,  maximum  negative 
inspiratory pressure, and spontaneous respiratory rate 
and tidal volume.
Weaning techniques
The post-ICU weaning strategy exclusively employed 
augmenting daily tracheal collar (venti-trach mask) 
or T-piece spontaneous breathing trials with return 
to assist-control (AC) mode ventilation. The treating 
physicians  and  respiratory  therapists  assessed 
each patient early every day. In addition to clinical 
Table 1. Criteria for transfer from the intensive care unit to the ventilator rehabilitation unit.
Respiratory stability Non-respiratory medical stability
Airway: tracheostomy for invasive ventilation Sepsis controlled
Secretions: manageable with infrequent suctioning no uncontrolled hemorrhage
Oxygenation: FIO2 , 50%, PeeP , 5 cm h2O, 
SaO2 . 92%
no uncontrolled arrhythmias, heart failure,   
or unstable angina
Ventilator settings: stable, volume control no coma
Patient assessment: comfortable, no increased 
WOB or dyspnea
Secure parenteral line
Weaning technique: tracheal collar Secure alimentation route
Abbreviations: PeeP, positive end-expiratory pressure; SaO2, oxygen saturation; WOB, work of breathing.Mamary et al
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assessment and observation of spontaneous   breathing 
respiratory mechanics {maximum   inspiratory   pressure 
(MIP), minute ventilation (VE) and its components of 
tidal volume (VT) and respiratory rate (f) and its ratio 
of  the  rapid  shallow  breathing  index  (f/VT)}  were 
measured and recorded. Based on patient tolerance, 
  stability  of  vital  signs  and  adequate  gas  exchange 
patients were progressively and totally weaned from 
assisted  ventilation  with  increasing  daily  efforts 
over days to weeks. Weaning success was defined as 
complete withdrawal of mechanical ventilation that 
persisted to hospital discharge.
Statistical analysis
Kaplan-Meier  analysis  was  used  to  construct  sur-
vival curves for all patients by diagnostic category. 
Log rank (Mantel-Cox) test was applied for pair-wise 
comparisons between categories of respiratory failure 
and patients grouped COPD vs. non-COPD.
Maximum likelihood estimates analysis was per-
formed for univariate associations between each patient 
characteristic  and  outcome.  A  multivariate  analysis 
using maximum likelihood estimates was performed 
for each significant univariate association (P # 0.05).
Results
Patient characteristics
During  the  study  period  182  patients  were  admit-
ted to the VRU for PMV. Table 2 shows the mean, 
total   hospital and ICU length of stays and duration 
of  PMV.  Table  3  shows  patient  characteristics  at 
VRU   admission. The study patients were generally 
older, with multiple comorbid illness, were severely 
Table 2. hours weaning and lengths of stay.
Variable Mean std Dev
# hours weaning prior 
to transfer to VRU
9.7 7.3
Total duration of mechanical 
ventilation (days)
55.0 42.7
ICU LOS (days) 39.7 36.5
VRU LOS (days) 38.8 48.1
Total hospital LOS (days) 74.7 57.6
note: ICU LOS and length of mechanical ventilation includes time at 
outside institutions; Total hospital LOS includes the time only at Temple 
University hospital.
Abbreviations:  ICU,  intensive  care  unit;  LOS,  length  of  stay;  VRU, 
ventilator rehabilitation unit.
Table 3. Patient characteristics (at VRU admission unless 
otherwise stated).
Variable Mean std Dev
Age (years) 64.1 15.6
Charlson Index (a.u.) 4.3 2.3
Left ventricular ejection fraction (%) 45.2 15.3
Albumin on hospital admission (g/dL) 2.7 1.8
Albumin on VRU admission (g/dL) 2.3 0.6
Albumin on discharge (g/dL) 2.6 0.7
APAChe II (a.u) 10.7 4.1
BMI (kg/m2) 28.7 11.3
hemoglobin (mg/dL) 9.7 1.4
Abbreviations: a.u., arbitrary units; APAChe II, acute physiology and 
chronic health evaluation II; BMI, body mass index.
Table 4. Lung mechanics.
Variable Mean std Dev
VRU admission
MIP (cm h2O)* 32.2 11.9
Ve (L/min) 7.5 5.0
PIP (cm h2O) 29.5 7.5
PP (cm h2O) 22.7 6.7
Last day of ventilation
MIP (cm h2O)* 38.5 15.1
Ve (L/min) 7.0 3.2
PIP (cm h2O) 27.6 6.5
PP (cm h2O) 20.5 5.6
note: * P  value  #  0.001  in  comparison  to  VRU  admission,  all  other 
variable were not significantly different.
Abbreviations: VRU, ventilator rehabilitation unit; MIP, maximal inspira-
tory  pressure;  Ve,  minute  ventilation,  PIP,  peak  inspiratory  pressure; 
PP, plateau pressure.
hypoalbuminemic and anemic. Mean left ventricu-
lar  ejection  fraction  determined  by  transthoracic 
  echocardiogram  (interpreted  by  cardiologist)  was 
low normal   (normal .45%). Table 4 shows respi-
ratory mechanics at VRU admission and at discon-
tinuation  of  mechanical  ventilation.  Overall  MIP 
increased 6.3 cm H2O from 32.2 ± 11.9 to 38.5 ± 15.1) 
(P , 0.001). The most common cause of respira-
tory failure was   pneumonia/ARDS (71 [39%]), fol-
lowed by CHF/CAD (42 [23%]), COPD (26 [14%]), 
post thoracic organ transplant (14 [8%]), obesity (11 
[6%]),  neurological  diseases  (9  [5%])  and  trauma 
(7 [4%]). Two patients were classified as other (tra-
cheal stenosis and asthma) 20.3% (37) of the 182 
experienced   respiratory failure following surgery and 
were classified as pneumonia/ARDS, COPD, CHF/Survival in prolonged ventilation
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associated  with  in-hospital  death  by  univariate 
  analysis (Table 6) include acute renal failure requir-
ing  hemo-dialysis,  any  hemo-dialysis,  comorbid 
congestive  heart  failure,  diabetes  mellitus,  higher 
Charlson co-morbidity index (more co-morbidities), 
APACHE II score (more severely ill), lower albumin 
at VRU admission, greater number of transfusions 
after  VRU  admission  and  higher  total  packed  red 
cell transfusions received during hospitalization. The 
number of transfusions received prior to VRU admis-
sion  was  not  associated  with  in-hospital  mortality, 
even when corrected for transfusions received during 
Pneumonia/ARDS n = 71
CHF/CAD n = 42
COPD n = 26
Transplant n = 14
Obesity n = 11
Neuro n = 9
Trauma n = 7
Other n = 2
Figure 2. The majority of patients had pneumonia, acute lung injury, 
heart failure, and COPD as the primary etiology for respiratory failure.
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Figure 3. Disposition of patients. Of all patients admitted to the ventilator 
rehabilitation unit, 81% survived and were discharged. 85% of the survivors 
were completely weaned from mechanical ventilation and 66% returned to 
home, either directly or after a period in a rehabilitation facility.
CAD or post thoracic organ transplant. The majority 
of these (25/37) were post-cardiac surgery who expe-
rience pneumonia or CHF as a cause of respiratory 
failure (Fig. 2).
81% of (147/182) patients admitted to the VRU sur-
vived to hospital discharge. Of these, 85% (125/147) 
were  completely  weaned  from  mechanical ventila-
tion (Fig. 3). Of the 22 not weaned, 13 patients were 
weaned to nocturnal ventilation and 9 were deemed 
unweanable.  Of  the  9  patients  requiring  chronic 
mechanical ventilation 6 were discharged to hospice. 
Of the remaining 3, 1 had West Nile Virus with acute 
and chronic quadriparetic myopathy, 1 very severe 
COPD and the other overlap syndrome (COPD and 
obesity hypoventilation).
Factors predictive of weaning failure
Patient  characteristics  associated  with  successful 
weaning  from  mechanical  ventilation  (univariate 
analysis) are shown in Table 5. Presence of COPD, 
higher body mass index (BMI) and longer total hospi-
tal length of say were associated with weaning failure. 
This negative association was retained in multivariate 
analysis for higher BMI (OR 0.951; CI 0.918–0.985; 
P , 0.005). The following characteristics were unre-
lated to weaning outcome: duration of mechanical 
ventilation, pre-VRU hospital length of stay, peak, 
plateau and maximal inspiratory pressure, or the pres-
ence of hypercapnia at VRU admission.
In-hospital mortality
81%  of  patients  admitted  to  the VRU  survived  to 
hospital discharge. In-hospital mortality after VRU 
admission was 19% (147/182) Patient   characteristics 
Table 5. Predictors of weaning success.
P value Odds ratio
Variable-univariate analysis
Longer total hospital LOS 0.027 0.988 (0.978–0.999)
COPD present 0.016 0.009 (0.001–0.417)
higher BMI 0.007 0.877 (0.796–0.965)
Variable-multivariate analysis
higher BMI 0.005 0.951 (0.918–0.985)
Abbreviations:  LOS,  length  of  stay;  BMI,  body  mass  index;  COPD, 
chronic obstructive pulmonary disease.Mamary et al
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  surgery. The association with increased mortality was 
retained in multivariate analysis for higher Charlson 
  co-morbidity  index,  higher APACHE  II  score  and 
lower albumin on VRU admission.
Disposition
Ultimately  65%  (96/147)  of  patients  went  home. 
44.9% (66) were discharged directly to home, 20.4% 
(30) were discharged to a rehabilitation facility then 
to home. 17.7% (26) were discharged to a nursing 
home, 9.5% (14) were discharged to a skilled nursing 
facility, 3% (2) were transferred to hospitals closer 
to home after complete weaning. 24% of the 9 (6%) 
unweanable, 6 were discharged to hospice and 3 to an 
LTAC for PMV. Figure 3 illustrates post-VRU dispo-
sition for all patients.
One and three year mortality
Post-VRU  discharge  survival  at  1  and  3  years  was 
75% and 59%. Patient characteristics associated with 
  out-of-hospital death by univariate analysis (Table 7) 
include  older  age,  lower  hemoglobin,  presence  of 
COPD, higher APACHE II score at VRU admission 
and higher number of packed red cell transfusions after 
VRU   admission. Charlson Index, APACHE II score and 
packed red cell transfusions were also associated with 
in-hospital death. The associations of higher APACHE II 
score on VRU admission, presence of COPD and lower 
hemoglobin with 1 and 3 year mortality were retained in 
multivariate analysis. Any diagnosis of COPD   (primary 
or secondary) worsened post discharge survival (HR 
1.91; 95% CI 1.075–3.42; P = 0.027) (Fig. 5).
Discussion
Generally our patients were in their 60’s, in the ICU 
about  30  days  before  transfer  for  weaning,  with 
multiple co-morbidities, had a left ventricular ejec-
tion fraction of 45%, were hypoalbuminemic, ane-
mic and had multiple comorbidities and an elevated 
APACHE  II  score.  Multiviariate  analysis  demon-
strated an association with higher BMI and failure to 
wean.   In-hospital mortality was similarly   association 
Table 6. Predictors of hospital mortality.
P value Odds ratio
Variable-univariate analysis
Become dialysis dependent during hospitalization 0.038 11.00 (1.14–106.43)
Dialysis dependent before respiratory failure 0.01 2.96 (1.29–6.81)
Diabetes mellitus 0.043 2.21 (1.03–4.75)
Congestive heart failure 0.042 2.20 (1.03–4.69)
# Transfusions in VRU ,0.0001 1.48 (1.23–1.79)
Charlson index at VRU admission ,0.0001 1.43 (1.20–1.69)
APAChe II score at VRU admission ,0.0001 1.24 (1.12–1.37)
# Transfusions—total hospitalization 0.026 1.049 (1.004–1.074)
higher albumin at VRU admission 0.01 0.39 (0.19–0.80)
Variable-multivariate analysis
higher charlson index 0.006 1.08–1.60
higher APAChe II score at VRU admission 0.016 1.03–1.29
higher albumin at VRU admission 0.027 0.17–0.90
Abbreviations: VRU, ventilator rehabilitation unit; APAChe II, acute physiology and chronic health evaluation II; BMI, body mass index.
Table 7. Predictors of long-term mortality.
P value Hazard ratio
Variable-univariate analysis
COPD present 0.003 1.31–3.7
Transfusions in VRU ,0.001 1.13–1.44
APAChe II score 
(at VRU admission)
,0.001 1.08–1.29
Age 0.054 1.00–1.04
Lower hemoglobin 
(at VRU admission)
0.002 0.55–0.87
Variable-multivariate analysis
COPD present 0.027 1.08–3.42
APAChe II score 
(VRU admission)
,0.0001 1.07–1.21
hemoglobin 
(VRU admission)
0.006 0.56–0.90
Abbreviations:  VRU,  ventilator  rehabilitation  unit; APAChe  II,  acute 
physiology and chronic health evaluation II.Survival in prolonged ventilation
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with  higher  Charlson  co-morbidity  index,  higher 
APACHE II score and lower albumin on VRU admis-
sion. Post-VRU discharge mortality was associated 
by  multivariate  analysis  with  higher  APACHE  II 
score and lower hemoglobin on VRU admission and 
the presence of COPD. Older age was did not retain 
significant association with short or long-term mor-
tality by multivariate analysis.
The literature contains several reports of the out-
comes  of  individual  weaning  centers,  each  with 
 center-specific admission and discharge criteria, wean-
ing protocols, diagnostic and therapeutic   capabilities 
and resource allocation.4–8,10,12–17 Each center treated 
a  patient  group  unique  in  demographics,  principal 
diagnoses,  comorbidities,  and  severities  of  illness. 
  Furthermore  the  published  descriptions  of  patients 
differ in detail and scope. Direct comparison of the 
experiences of different centers must be limited and 
cautious. For example Gracey and colleagues reported 
the outcomes of .60% post-surgical patients as 90.2% 
hospital survival and 72% 2-year survival.15 Whereas 
Stoller  reported  30%  post-surgical  patients  as  84% 
hospital and only 32% 2-year   survival.5 Such differ-
ences in patient populations make it difficult to com-
pare results between studies and limit the application 
of the findings in a broader context.
The focus of post-PMV outcomes literature has 
evolved in small increments since its origins in the 
1980’s. An early paper by Gillespie and colleagues 
examined weaning and hospital survival outcomes of 
patients requiring invasive ventilation .24 hours.14 In 
this setting, prior to a dedicated weaning unit model, 
they looked at the aggregate experience of the surgi-
cal and medical ICUs in a single hospital. 327 patients 
age 62.2 ± 17.7 years ventilated 11.8 ± 20.1 days had 
a 33.9% hospital mortality. The patients were subdi-
vided into six groups of respiratory failure including 
post-surgical, medical, acute lung injury, respiratory 
failure with and without multisystem organ failure 
and previous lung disease (mostly COPD). Hospital 
mortality was highest in respiratory failure with mul-
tisystem organ failure. One-year mortality was high-
est in non-surgical COPD patients. This scheme was 
emulated by Gracy in 1992 who reported excellent 
hospital, one and two year survivals in a predomi-
nantly post-surgical population without multisystem 
organ  failure  and  minimal  chronic  lung  disease.18 
Scheinhorn and colleagues recognized the need for 
diagnosis  related  weaning  success/failure  analysis. 
He classified 206 patients into one of five diagnos-
tic groups: acute pneumonia with underlying COPD, 
aspiration pneumonia with underlying neuromuscular 
disease, cardiac/thoracic surgery, CABG with severe 
CHF and Sepsis with ARDS. Relatively small num-
bers in each group limited the results. The authors 
concluded that “Larger numbers of patients in each 
combined-diagnosis  subgroup  would  allow  us  to 
translate the sub-group weaning outcomes into reason-
able expectation of weaning success”.8 No diagnostic 
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Figure 5. Kaplan-Meier Survival Curve in COPD vs. non COPD patients. 
Patients with COPD (either as a primary cause of respiratory failure or 
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tory failure. Although not statistically significant, patients with trauma 
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group related survival analysis was presented. Others 
applied unique respiratory failure diagnostic classi-
fication  schemes  to  weaning  success/failure  analy-
sis with varied results.4,7,10,17 Pilcher and colleagues 
describe in-hospital survival according to three cat-
egories  of  respiratory  failure:  neuromuscular/chest 
wall, COPD and post-surgical.10 Long-term survival 
was not reported. Quinnel and colleagues described 
the long term survival in 76 patients with respiratory 
failure secondary to COPD who were weaned from 
prolonged mechanical ventilation.16 However, in the 
subsequent literature there has been no clarification or 
standardization of a categorization scheme for causes 
of prolonged respiratory failure. As a result, survival 
outcomes analysis has been limited to less incisive 
analysis of the negative impact of patient attributes 
such as age, serum albumin and severity of illness.
The survival analysis presented in this report offers 
a  comprehensively  characterized  group  of  patients 
receiving prolonged mechanical ventilation. Of par-
ticular importance, we extracted diagnostic etiologies 
for prolonged respiratory failure as documented by 
the treating physicians. The seven categories chosen 
were thought to reflect a primary physiologic mecha-
nism that determined need for invasive mechanical 
ventilation. For example “CAD/CHF” indicates left 
ventricular  dysfunction,  volume  overload,  possible 
ischemia and hypoxemia; “neuro” indicates respira-
tory pump weakness, whole body weakness and risk 
for pneumonia; “COPD” indicates static and dynamic 
hyperinflation, bronchospasm and inspiratory muscle 
weakness and so forth. We chose these categories over 
the more general “surgical vs. non-surgical” because 
of the mechanistic information contained in each. It is 
important to recognize that weakness, impaired nutri-
tion, swallowing dysfunction, and a need for total 
body rehabilitation is nearly universal in prolonged 
mechanical ventilation regardless of the etiology.
We demonstrated a statistically significant out-of-
hospital survival difference between patients with 
neurological respiratory failure and obesity related 
respiratory  failure  (neuro  ,  obesity,  P  =  0.05; 
  Fig. 4). The neuro group included patients with acute 
catastrophic illness, such as stroke or Guillain-Barre 
syndrome, with a subsequent recovery of some or 
all functions, whereas the morbidly obese (with an 
average BMI of 56.4 kg/m2) with hypoventilation 
syndrome and right sided heart failure had morbid 
chronic  complications  secondary  to  their  weight 
such as diabetes mellitus, supraventricular arrhyth-
mia, venous thrombosis, pneumonia and difficulty 
using  non-invasive  positive  pressure  ventilation 
Non-significant  visual  trends  toward  survival  dif-
ferences between neuro and. COPD and neuro and 
CHF/CAD  invoke  the  limitation  of  small  patient 
numbers.
Of  all  the  patients  who  lived  to  be  discharged 
(147),  85%  were  completely  weaned  of  mechani-
cal ventilation and only 6% were deemed unwean-
able. Interestingly, failure to wean was not related 
to  lung  mechanics,  hypercapnia,  or  time  spent  on 
mechanical ventilation. The presence of COPD and 
severe obesity was associated with failure to wean. 
This is similar to Dasgupta’s results in which a cause 
of respiratory failure other than COPD was associ-
ated with improved weaning success.4 A significant 
increase was observed in pre-weaning MIP vs. the last 
day of mechanical ventilation, reinforcing the role of 
respiratory muscle weakness in prolonged respira-
tory failure and the importance of rehabilitation and 
restoration of skeletal muscle strength in success-
ful  weaning.  Our  rehabilitation  protocol  included 
daily physical therapy, inspiratory muscle strength 
training. Skeletal muscle weakness is undoubtedly 
more complex than simple deconditioning and likely 
results  from  systemic  oxidative  and  nitrosydative 
stress and inflammation related to acute and chronic 
illness. This has been demonstrated in animal stud-
ies and in COPD. Prospective study of inflammatory 
biomarkers, optimal rehabilitation duration and fre-
quency, skeletal and diaphragm muscle morphology 
and function during the ventilator rehabilitation and 
weaning  process  will  give  greater  meaning  to  the 
observed improvement in MIP.
Long-term survival one year after VRU   discharge 
was  75%,  67%  at  2  years  and  59%  after  3  years 
  similar to Gracey and colleagues. who reported 1, 2 
and 3 year survival of 69%, 60% and 56% in a largely 
post-surgical group (60%).15 In contrast, only 26% 
of the present studies patients experienced respira-
tory failure after surgery vs. 60%. Our survival data 
is substantially higher than that reported by others in 
which the 1, 2 and 3 year survivals were 43%, 32% 
and 27%.5 It is difficult to compare results between Survival in prolonged ventilation
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centers.  It  is  easy  to  speculate  that  inter-  center 
  differences  are  due  to  non-patient  related  factors 
such as experience, resources, protocols, and supe-
rior homecare after discharge. Our patient data cor-
respond to the years 2000–2004. During the interval 
1993–1996 to 2000–2004, new treatments may have 
contributed to better survival, such as new weaning 
techniques,19–21 protocol driven care,22–24 less use of 
sedation and paralytic agents,25 and better home care 
delivery.
Degree of anemia, higher APACHE II scores at 
VRU  admission  and  the  presence  of  COPD  as  a 
comorbidity  correlate  with  poorer  long  term  sur-
vival. Hemoglobin level is likely an epimarker for 
severity of illness. However it must be recognized 
that treatment of anemia with red cell transfusion or 
erythropoietin  analogue  may  negatively  influence 
survival.26,27
Summary
We report 81% survival to hospital discharge in a 
heterogeneous  group  of  patients  with  respiratory 
  failure requiring PMV and rehabilitation in a mul-
tidisciplinary VRU. Of the hospital survivors, 85% 
were completely weaned from invasive mechanical 
ventilation. Combined post-VRU discharge survival 
was 75% at 1 year and 59% at 3 years. Severity of ill-
ness at VRU admission characterized by APACHE II 
score  and  degree  of  anemia  negatively  influenced 
survival. Of the 7 diagnostic etiologies of prolonged 
respiratory  failure  “COPD”  had  the  poorest  post-
VRU survival.
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